Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

卵巢癌复发治疗的研究进展

Shan LIU,Jing WANG,Lu LIU,Peilin OUYANG

Anti-Tumor Pharmacy（2019）

Cited 0|Views3
No score
Abstract
卵巢癌是妇科常见的恶性肿瘤,其病死率及复发率均居妇科恶性肿瘤之首,对于复发性卵巢癌的治疗一直是研究的热点.大量临床试验研究了二次细胞减灭术、化疗和靶向药物等复发性卵巢癌的治疗方案,尤其是对贝伐珠单抗、PARP酶抑制剂等靶向治疗方案的研究,取得了突破性进展.多种PARP酶抑制剂药物获准用于临床,为复发性卵巢癌的治疗提供了更多的选择.本文主要就卵巢癌复发治疗的研究进展进行了综述.
More
Translated text
Key words
Recurrent ovarian cancer,Secondary cytoreductive surgery,Targeted medicine,Bevacizumab,PARP inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined